Back to Search
Start Over
565P Genome-guided targeted therapy combination improves survival in patients with advanced EGFR mutation positive NSCLC failing osimertinib.
- Source :
-
Annals of Oncology . 2023 Supplement 4, Vol. 34, pS1690-S1690. 1p. - Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173758522
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.10.643